{"id":"https://openalex.org/W2010898739","doi":"https://doi.org/10.1159/000248432","title":"Normalization of Skin Appearance in a Patient with Scleromyxoedema after Intensive Chemotherapy for Hodgkin\u2019s Disease","display_name":"Normalization of Skin Appearance in a Patient with Scleromyxoedema after Intensive Chemotherapy for Hodgkin\u2019s Disease","publication_year":2009,"publication_date":"2009-10-09","ids":{"openalex":"https://openalex.org/W2010898739","doi":"https://doi.org/10.1159/000248432","mag":"2010898739","pmid":"https://pubmed.ncbi.nlm.nih.gov/2767291"},"language":"en","primary_location":{"id":"doi:10.1159/000248432","doi":"https://doi.org/10.1159/000248432","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000248432","pdf_url":null,"source":{"id":"https://openalex.org/S4210236055","display_name":"Dermatologica","issn_l":"0011-9075","issn":["0011-9075","2571-7197"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109174690","display_name":"Adina Alberts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I69552723","display_name":"University of Pretoria","ror":"https://ror.org/00g0p6g84","country_code":"ZA","type":"education","lineage":["https://openalex.org/I69552723"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"A.S. Alberts","raw_affiliation_strings":["Department of Medical Oncology, University of Pretoria, South Africa","Medical Oncology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, University of Pretoria, South Africa","institution_ids":["https://openalex.org/I69552723"]},{"raw_affiliation_string":"Medical Oncology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083972171","display_name":"E. Schulz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I192619145","display_name":"University of the Witwatersrand","ror":"https://ror.org/03rp50x72","country_code":"ZA","type":"education","lineage":["https://openalex.org/I192619145"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"E.J. Schulz","raw_affiliation_strings":["Division of Dermatology, University of the Witwatersrand, Johannesburg, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Dermatology, University of the Witwatersrand, Johannesburg, South Africa","institution_ids":["https://openalex.org/I192619145"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035654267","display_name":"Geoffrey Falkson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Geoffrey Falkson","raw_affiliation_strings":["Medical Oncology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000995351","display_name":"I. W. Simson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I69552723","display_name":"University of Pretoria","ror":"https://ror.org/00g0p6g84","country_code":"ZA","type":"education","lineage":["https://openalex.org/I69552723"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"I.W. Simson","raw_affiliation_strings":["Anatomical Pathology, University of Pretoria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anatomical Pathology, University of Pretoria","institution_ids":["https://openalex.org/I69552723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112694994","display_name":"Maria Antonia Coccia-Portugal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M.A. Coccia-Portugal","raw_affiliation_strings":["Medical Oncology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3976,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.63235366,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"178","issue":"4","first_page":"221","last_page":"224"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.67330002784729,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.67330002784729,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12433","display_name":"Skin Diseases and Diabetes","score":0.07980000227689743,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.047600001096725464,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/scleromyxoedema","display_name":"scleromyxoedema","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hodgkin-lymphoma","display_name":"Hodgkin's disease","score":0.8840000033378601},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.5479999780654907},{"id":"https://openalex.org/keywords/cytostatic-drugs","display_name":"cytostatic agents","score":0.9459999799728394},{"id":"https://openalex.org/keywords/skin-lesions","display_name":"skin lesions","score":0.640999972820282},{"id":"https://openalex.org/keywords/drug-induced-skin-disease","display_name":"drug-induced skin disease","score":0.36000001430511475}],"concepts":[{"id":"https://openalex.org/C136886441","wikidata":"https://www.wikidata.org/wiki/Q926129","display_name":"Normalization (sociology)","level":2,"score":0.7508135437965393},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6567500829696655},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5848392844200134},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5802649259567261},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5652094483375549},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33556726574897766},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3039230406284332},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C19165224","wikidata":"https://www.wikidata.org/wiki/Q23404","display_name":"Anthropology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006689","descriptor_name":"Hodgkin Disease","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006689","descriptor_name":"Hodgkin Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009230","descriptor_name":"Myxedema","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009230","descriptor_name":"Myxedema","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009230","descriptor_name":"Myxedema","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012594","descriptor_name":"Scleroderma, Localized","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D012594","descriptor_name":"Scleroderma, Localized","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012594","descriptor_name":"Scleroderma, Localized","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1159/000248432","doi":"https://doi.org/10.1159/000248432","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000248432","pdf_url":null,"source":{"id":"https://openalex.org/S4210236055","display_name":"Dermatologica","issn_l":"0011-9075","issn":["0011-9075","2571-7197"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologica","raw_type":"journal-article"},{"id":"pmid:2767291","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2767291","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatologica","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2045289012","https://openalex.org/W1965301595","https://openalex.org/W2472389843","https://openalex.org/W2029538983","https://openalex.org/W2082212260","https://openalex.org/W7132924317","https://openalex.org/W2091400072","https://openalex.org/W2120625655","https://openalex.org/W2037865374","https://openalex.org/W2409982266"],"abstract_inverted_index":{"A":[0],"patient":[1],"with":[2,9],"scleromyxoedema":[3,50],"was":[4],"treated":[5],"for":[6,40],"6":[7,25],"years":[8,26],"cytostatic":[10,37,66],"drugs.":[11,67],"During":[12],"this":[13],"time":[14],"the":[15,32,49,64],"skin":[16],"lesions":[17],"followed":[18],"a":[19],"fluctuating":[20],"but":[21],"progressive":[22],"course.":[23],"After":[24],"she":[27],"developed":[28],"Hodgkin's":[29,41,55],"lymphoma":[30],"of":[31,48,54],"mixed":[33],"cellularity":[34],"type.":[35],"Intensive":[36],"treatment":[38],"given":[39],"disease":[42,56],"resulted":[43],"in":[44],"virtually":[45],"complete":[46],"disappearance":[47],"lesions.":[51],"The":[52],"development":[53],"is":[57],"considered":[58],"fortuitous":[59],"and":[60],"not":[61],"due":[62],"to":[63],"previous":[65]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}